Anales de la RANM

66 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 FENOTIPO DE LA Β-TALASEMIA INTERMEDIA Paloma Ropero, et al. An RANM. 2021;138(01): 60 - 71 XXXVIII 24/M 10.2 68.5 21.4 19.7 2.6 XXXIX 23/H 10.4 60.7 18.4 17.3 1.9 XL 24/H 10.4 60.7 18.4 17.3 1.9 XLI 18/H 10.4 65.4 20.8 17.3 1.3 XLII X/H 10.5 61.6 19.2 14.8 2.3 XLIII 10/M 10.6 57.3 18.7 16.8 0.9 XLIV 19/M 10.7 62.7 21.0 16.1 2.2 XLV 25/M 11.0 60.0 20.5 15.7 1.1 XLVI 26/H 12.5 66.1 21.1 15.4 1.0 XLIVII 35/M 9.2 66.5 21.7 33.1 4.4 XLVIII X/M 9.0 63.8 18.5 20.9 5.5 XLIX 12/M 8.8 62.8 19.4 18.4 2.3 L X/M 8.1 63.7 19.7 17.9 1.7 LI 22/M 8.2** 63.4 20.6 16.1 2.4 LII 5m/M 8.4 78.7 25.6 18.7 2.5 LIII 21/M 8.6 63.4 20.6 16.1 2.4 LIV 20/M 10.3 61.2 19.6 17.1 2.1 LV 10/H 10.8 60.3 18.7 16.6 2.0 LVI 38/H 11.0 59.3 18.5 16.5 3.0 LVII 24/H 11.6 60.1 17.2 16.2 1.1 LVIII X/H 12.2 58.7 18.8 16.9 0.9 LIX 27/H 12.4 61.8 19.6 16.6 1.4 LX X/M 12.9 63.4 20.0 15.5 1.4 LXI X/H 13.4 62.6 20.2 17.0 1.8 LXII X/H 13.5 63.3 20.3 16.7 1.3 LXIII 22/H 13.8 61.0 19.4 15.0 1.5 LXIV 11/H 10.1 60.2 18.4 16.6 2.2 LXV X/M 8.3 74.3 20.9 32.7 2.9 LXVI X/M 11.3 75.0 22.2 19.4 0.2 LXVII 60/H 11.4 74.5 23.5 16.2 1.9 LXVIII X/H 12.6 68.7 22.2 14.6 0.6 LXIX 4/M 9.4 75.8 21.9 24.8 4.4 LXX 49/M 12.1 73.2 23.7 23.0 1.3 LXXI 37/H 12.3 67.7 20.1 23.0 2.2 LXXII 31/H 14.0 71.9 22.2 24.5 1.6 LXXIII X/M 11.9 66.9 22.2 19.4 2.5 II III H=hombre; M=Mujer; *transfusión-dependiente; **embarazada; §quelación con deferroxamina; ***esplenectomizado a los 2 años